# AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects

> **NCT04107441** · PHASE1 · COMPLETED · sponsor: **Axalbion SA** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AX-8 Part 1
- **DRUG:** AX-8 Part 2

## Key facts

- **NCT ID:** NCT04107441
- **Lead sponsor:** Axalbion SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-09
- **Primary completion:** 2020-02-25
- **Final completion:** 2020-03-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04107441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04107441, "AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04107441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*